BOT 0.00% 32.0¢ botanix pharmaceuticals ltd

I think we need to take stock here guys:- We have the FDA...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 836 Posts.
    lightbulb Created with Sketch. 488
    I think we need to take stock here guys:

    - We have the FDA approval!!!!!!

    - We now have sufficient cash in the bank to fund an immediate launch.

    - We were always going to need cash for this and Matt never made a secret of it - he said “it’s kind of a nice problem to have”.

    - Like it or not we need the sophs and instos to raise the cash - remember what happened the last time they came to us for a raise? It’s no surprise that they need an incentive to dig into their pockets.

    - The share price is currently14% above the raise price and 23% above where it was a week ago.

    - Price action on the opening day with both an FDA approval and a CR was always going to be difficult to predict. It simply is what it is.

    - We have to credit the team that has brought us this far with having enough brains to have made the best decisions for the circumstances. Are any of us really qualified to make better decisions than they are? Remember they are shareholders too and their sights are not set on maximising today’s share price.

    We’re in a safe position with massive potential aheas of us - enjoy it.

    Last edited by Justanovice: 21/06/24
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
32.0¢
Change
0.000(0.00%)
Mkt cap ! $581.5M
Open High Low Value Volume
32.5¢ 32.5¢ 31.5¢ $1.940M 6.061M

Buyers (Bids)

No. Vol. Price($)
17 470483 31.5¢
 

Sellers (Offers)

Price($) Vol. No.
32.0¢ 33000 1
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.